2003 FDA, Center & ORA Scientific Achievement Award Recipients
Outstanding Poster Awards


Congratulations are in order!

The 2003 FDA Scientific Achievement Award recipients, and the Sigma Xi Best Poster Award recipients
announced at the Scientific Achievement Awards Ceremony on April 24, 2003 in Washington, DC are as follows:




EXCELLENCE IN ANALYTICAL SCIENCE
Keith Andrew Wear, Ph.D., Center for Devices and Radiological Health
For scientific research and regulatory support in the area of ultrasound bone densitometry


EXCELLENCE IN LABORATORY SCIENCE
Serge Beaucage, Ph.D., Center for Biologics Evaluation and Research
For invention of methods, applications, and reagents of phosphoramidite chemistry, the foundation of PCR and sequencing primers, rapid and efficient solid-phase synthesis of antisense oligonucleotides and their analogues and diagnostic probes


EXCELLENCE IN REVIEW SCIENCE
Elliot P. Cowan, Ph.D., Center for Biologics Evaluation and Research
For bringing rapid HIV tests to market to meet a critical public health need and developing policy to facilitate their approval and use


OUTSTANDING INTERCENTER SCIENTIFIC COLLABORATION
OP-1 Implant HDE Review Team
For outstanding collaboration in the review and recommended approval of a novel implant device

Carol A. Arras, M.S., CDRH
Jan C. Callaway, CDRH
Ann H. Costello, Ph.D., D.M.D., CDRH
Pete L. Hudson, Ph.D., CDRH
Mark N. Melkerson, M.S., CDRH
Diane A. Mitchell, M.D., CDRH
Theodore R. Stevens, M.S., CDRH
Jean Toth-Allen, Ph.D., CDRH
Paul A. Williams, CDRH
Celia M. Witten, Ph.D., M.D., CDRH
Mary Ann Wollerton, M.P.A., CDRH
Barry Cherney, Ph.D., CBER
Harold Dickensheets, Ph.D., CBER
CDR John Hill, Ph.D., CBER **
Gary Kikuchi, Ph.D., CBER
Elizabeth Shores, Ph.D., CBER
Bette Goldman, R.N., M.P.H., CBER
Amy S. Rosenberg, M.D., CBER
Ghanshyam Gupta, Ph.D., CBER
Mercedes A. Serabian, M.S., CBER
James G. Farrelly, Ph.D., CDER
CAPT Debra Lewis, O.D., OC **
Janet L. Witley, Ph.D., OC
CDR Mutahar Shamsi, M.S., ORA **
Susan Walker, M.D., CFSAN
Angel Torres-Cabassa, Ph.D., CDRH
Nirmal Mishra, D.V.M., Ph.D., CDRH



CENTER AWARDEES FOR EXCELLENCE IN ANALYTICAL SCIENCE

CENTER AWARDEES FOR EXCELLENCE IN LABORATORY SCIENCE

CENTER AWARDEES FOR EXCELLENCE IN REVIEW SCIENCE

OUTSTANDING INTERCENTER SCIENTIFIC COLLABORATION

Deborah A. Loveys, Ph.D., ORA
For outstanding and continuing contributions to the development and implementation of analytical methods and training related to the detection of bioterrorist pathogens and viral contaminants in FDA regulated products


Chromatography Media Decay Evaluation Team
For outstanding efforts to establish scientific data driven FDA policy on chromatography media reuse in biotechnology product manufacture

Kurt Brorson, Ph.D., CBER
Janice Brown, M.S., CDER
Elizabeth Hamilton, CBER


OP-1 Implant HDE Review Team
For outstanding collaboration in the review and recommended approval of a novel implant device

Carol A. Arras, M.S., CDRH
Jan C. Callaway, CDRH
Ann H. Costello, Ph.D., D.M.D., CDRH
Pete L. Hudson, Ph.D., CDRH
Mark N. Melkerson, M.S., CDRH
Diane A. Mitchell, M.D., CDRH
Theodore R. Stevens, M.S., CDRH
Jean Toth-Allen, Ph.D., CDRH
Paul A. Williams, CDRH
Celia M. Witten, Ph.D., M.D., CDRH
Mary Ann Wollerton, M.P.A., CDRH
Barry Cherney, Ph.D., CBER
Harold Dickensheets, Ph.D., CBER
CDR John Hill, Ph.D., CBER **
Gary Kikuchi, Ph.D., CBER
Elizabeth Shores, Ph.D., CBER
Bette Goldman, R.N., M.P.H., CBER
Amy S. Rosenberg, M.D., CBER
Ghanshyam Gupta, Ph.D., CBER
Mercedes A. Serabian, M.S., CBER
James G. Farrelly, Ph.D., CDER
CAPT Debra Lewis, O.D., OC **
Janet L. Witley, Ph.D., OC
CDR Mutahar Shamsi, M.S., ORA **
Susan Walker, M.D., CFSAN
Angel Torres-Cabassa, Ph.D., CDRH
Nirmal Mishra, D.V.M., Ph.D., CDRH


Coronary Drug-Eluting Stent Regulatory Review Team
For superior intercenter collaboration between CDRH and CDER in developing a regulatory strategy in the scientific review of novel drug-eluting coronary stents, a combination product

Ashley B. Boam, MSBE, CDRH
Xiao-Hong Chen, Ph.D., CDER
Nallaperumal Chidambaram, Ph.D., CDER
Albert Defelice, Ph.D., CDER
Jonette Rogers Foy, Ph.D., CDRH
John Francis Glass, M.P.H., CDRH
Jennifer L. Goode, B.S., CDRH
John E. Hyde, M.D., Ph.D., CDRH
Donald Nick Jensen, D.V.M., M.S., CDRH
Patrick John Marroum, Ph.D., CDER
Kasturi Srinivasachar, Ph.D., CDER
John Edward Stuhlmuller, M.D., CDRH
Belay Tesfamariam, Ph.D., CDER
Douglas C. Throckmorton, M.D., CDER
Carolyn Vaughan, B.S., CDRH
Bram David Zuckerman, M.D., CDRH


** Commissioned Corps

For additional information, please call the Office of Science and Health Coordination at 301-827-3340



POSTER AWARDS FOR THE 2002 FDA SCIENCE FORUM
Presented by the FDA Chapter of Sigma Xi




1st Place Ribbon First Place Poster - 2003 FDA Science Forum

Board O-07
Systemic and Local Drug Delivery Inhibit Vascular Stenosis Following Angioplasty and Grafting: Safety and Effectiveness and Routes of Administration
J.W.Karanian1, N.Kipshidze2, D.Wray-Cahen1, S.L.Hilbert1, A.Ashby1, W.F.Pritchard1, 1OST, CDRH, FDA, 2Lenox Hill Hospital , NY, NY
Abstract


2nd Place Ribbon Second Place Poster - 2003 FDA Science Forum

Board F-15
Microbial Source Tracking (MST) of Foodborne Salmonella & Campylobacter
R.Singh, S.L.Foley, D.G.White, S.Zhao, S.Simjee, P.F.McDermott, R.D.Walker, Center for Veterinary Medicine, FDA, Laurel, MD
Abstract


3rd Place Ribbon Third Place Poster - 2003 FDA Science Forum

Board I-10
Comparative analysis of the detection of vaccinia virus antigens by human polyclonal immune globulin preparations

M.G.Mikolajczyk, N.L.Eller, A.Jones-Trower, M.Kennedy, D.E.Scott, CBER, FDA, Bethesda, MD
Abstract


Honorable Mention Ribbon Honorable Mention Poster - 2003 FDA Science Forum

Board G-09
Improved Enrichment for Enterohemorrhagic Escherichia coli (EHEC) by Exposure to Extremely Acidic Conditions

M.A.Grant, ORA, Pacific Regional Laboratory Northwest, FDA, Bothell, WA 98021
Abstract


Honorable Mention Ribbon Honorable Mention Poster - 2003 FDA Science Forum

Board B-01
Microarray Detection of Antibiotic Drug Resistant Strains of Mycobacterium tuberculosis (MTB)

X.Tang1, S.L.Morris2, J.J.Langone1, S.A.Khan3, P.M.Regan4, L.E.Bockstahler1, 1CDRH, FDA, Rockville, MD 20857, 2CBER, FDA, Rockville, MD 20857, 3NCTR, FDA, Jefferson, AR 72079, 4WEAC, ORA, FDA, Winchester, MA 01890
Abstract


Honorable Mention Ribbon Honorable Mention Poster - 2003 FDA Science Forum

Board I-05
Isolation and Identification of Bacillus anthracis from food

B.D.Tall1, S.Monday1, M.H.Kothary2, D.Hao1, D.E.Hanes2, T.S.Hammack1, D.H.Burr2, 1FDA, College Park, MD, 20740, 2FDA, Laurel, MD, 20708
Abstract


People's Choice Winner Ribbon People's Choice Award - 2003 FDA Science Forum

Board G-12
Transfusion Related Fatalities from Bacterial Contamination of Blood Components

L.E.Simmons, MT(ASCP)1, M.A.Knippen2, L.G.Holness, M.D.3, 1OCBQ, CBER, FDA, Rockville, MD, 2OCBQ, CBER, FDA, Rockville, MD, 3OBRR, CBER, FDA, Rockville, MD
Abstract


Clear Science Communication Winner Ribbon Clear Science Communication Award - 2003 FDA Science Forum

Board A-29
Validation of Methods to Confirm Chloramphenicol at 0.1 ppb in Shrimp, Crabmeat, and Honey: Collaboration between FDA CVM, FDA Office of Regulatory Affairs, Florida Dept. of Agriculture and Consumer Affairs, and the Canadian Food Inspection Agency

M.C.Carson, C.B.Nochetto, D.N.Heller, K.Ferbos, P.J.Kijak, Division of Residue Chemistry, Office of Research, CVM, Laurel MD 20708
Abstract


Clear Science Communication Winner Ribbon Clear Science Communication Award - 2003 FDA Science Forum

Board D-03
Evaluating the Safety and Effectiveness of "Aberration-Free" Ophthalmic Refractive Surgery

B.Drum, M.Eydelman, G.Hilmantel, CDRH, FDA, Rockville, MD
Abstract


Clear Science Communication Winner Ribbon Clear Science Communication Award - 2003 FDA Science Forum

Board T-03
Studies in Pregnant Women: Pharmacokinetic/Pharmacodynamic and Fetal Safety

D.Kennedy, K.Uhl, K.Chapman, M.A.Miller, FDA, Rockville, MD
Abstract


Clear Science Communication Winner Ribbon Clear Science Communication Award - 2003 FDA Science Forum

Board W-08
Did Drugs Withdrawn in Recent Years Have Greater Risk in Women? Findings From Postmarketing Reporting of Adverse Events Data

M.C.Chen1, S.M.Huang2, J.Beitz1, R.Temple3, 1Office of Drug Safety, , 2Office of Clinical Pharmacology and Biopharmaceutics, , 3Office of Medical Policy, CDER, FDA, Rockville, MD
Abstract



2003 FDA Science Forum | FDA Chapter, Sigma Xi | CFSAN | FDA
Last updated on 2003-APR-29 by frf